137 related articles for article (PubMed ID: 36319022)
21. The natural history and prognosis of rheumatoid arthritis: association of radiographic outcome with process variables, joint motion and immune proteins.
Graudal N
Scand J Rheumatol Suppl; 2004; 118():1-38. PubMed ID: 15180092
[TBL] [Abstract][Full Text] [Related]
22. Rheumatoid inflammation and joint destruction: cause and effect or parallel phenomena?
Williams JD; Scott DL; DeBrito FB; Willoughby DA; Huskisson EC
Agents Actions; 1986 Aug; 18(5-6):538-43. PubMed ID: 3766311
[TBL] [Abstract][Full Text] [Related]
23. Predictive factors for radiographic progression of large joint damage in patients with rheumatoid arthritis treated with biological disease-modifying antirheumatic drugs (bDMARDs): Results of 3 to 4 years of follow-up.
Nakajima A; Terayama K; Sonobe M; Aoki Y; Takahashi H; Akatsu Y; Taniguchi S; Yamada M; Kubota A; Nakagawa K
Mod Rheumatol; 2019 Nov; 29(6):903-909. PubMed ID: 30285585
[No Abstract] [Full Text] [Related]
24. Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study.
Garnero P; Landewé R; Boers M; Verhoeven A; Van Der Linden S; Christgau S; Van Der Heijde D; Boonen A; Geusens P
Arthritis Rheum; 2002 Nov; 46(11):2847-56. PubMed ID: 12428224
[TBL] [Abstract][Full Text] [Related]
25. The clinical features of rheumatoid arthritis.
Grassi W; De Angelis R; Lamanna G; Cervini C
Eur J Radiol; 1998 May; 27 Suppl 1():S18-24. PubMed ID: 9652497
[TBL] [Abstract][Full Text] [Related]
26. Performance of computer-based analysis using temporal subtraction to assess joint space narrowing progression in rheumatoid patients.
Ichikawa S; Kamishima T; Sutherland K; Okubo T; Katayama K
Rheumatol Int; 2016 Jan; 36(1):101-8. PubMed ID: 26298417
[TBL] [Abstract][Full Text] [Related]
27. Predictive role of ultrasound remission for progressive ultrasonography-detected structural damage in patients with rheumatoid arthritis.
Liu F; Li W; Zhu J; Liu F; Fan W; Chen Z
J Investig Med; 2022 Feb; 70(2):391-395. PubMed ID: 34518320
[TBL] [Abstract][Full Text] [Related]
28. Personalizing treatment targets in rheumatoid arthritis by using a simple prediction model.
de Punder YM; Jansen TL; van Ede AE; den Broeder AA; van Riel PL; Fransen J
J Rheumatol; 2015 Mar; 42(3):398-404. PubMed ID: 25593241
[TBL] [Abstract][Full Text] [Related]
29. Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis.
Plant MJ; Williams AL; O'Sullivan MM; Lewis PA; Coles EC; Jessop JD
Arthritis Rheum; 2000 Jul; 43(7):1473-7. PubMed ID: 10902748
[TBL] [Abstract][Full Text] [Related]
30. [Assessment of joint structure in patients with rheumatoid arthritis].
Tanaka Y
Clin Calcium; 2013 Mar; 23(3):409-17. PubMed ID: 23445895
[TBL] [Abstract][Full Text] [Related]
31. Health assessment questionnaire-disability index (HAQ-DI) score at the start of biological disease-modifying antirheumatic drug (bDMARD) therapy is associated with radiographic progression of large joint damage in patients with rheumatoid arthritis.
Nakajima A; Aoki Y; Terayama K; Sonobe M; Takahashi H; Saito M; Nakagawa K
Mod Rheumatol; 2017 Nov; 27(6):967-972. PubMed ID: 28271947
[TBL] [Abstract][Full Text] [Related]
32. Decrease in bone mineral density during three months after diagnosis of early rheumatoid arthritis measured by digital X-ray radiogrammetry predicts radiographic joint damage after one year.
Ziegelasch M; Forslind K; Skogh T; Riklund K; Kastbom A; Berglin E
Arthritis Res Ther; 2017 Sep; 19(1):195. PubMed ID: 28865482
[TBL] [Abstract][Full Text] [Related]
33. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.
Lipsky PE; van der Heijde DM; St Clair EW; Furst DE; Breedveld FC; Kalden JR; Smolen JS; Weisman M; Emery P; Feldmann M; Harriman GR; Maini RN;
N Engl J Med; 2000 Nov; 343(22):1594-602. PubMed ID: 11096166
[TBL] [Abstract][Full Text] [Related]
34. Meta-analysis suggests that intensive non-biological combination therapy with step-down prednisolone (COBRA strategy) may also 'disconnect' disease activity and damage in rheumatoid arthritis.
Boers M; van Tuyl L; van den Broek M; Kostense PJ; Allaart CF
Ann Rheum Dis; 2013 Mar; 72(3):406-9. PubMed ID: 23155223
[TBL] [Abstract][Full Text] [Related]
35. Large-joint damage in patients with early rheumatoid arthritis and its association with treatment strategy and damage of the small joints.
Dirven L; van den Broek M; Kroon HM; Grillet BA; Han KH; Kerstens PJ; Huizinga TW; Lems WF; Allaart CF
Rheumatology (Oxford); 2012 Dec; 51(12):2262-8. PubMed ID: 22942403
[TBL] [Abstract][Full Text] [Related]
36. Predictive factors associated with the progression of large-joint destruction in patients with rheumatoid arthritis after biologic therapy: A post-hoc analysis using FDG-PET/CT and the ARASHI (assessment of rheumatoid arthritis by scoring of large-joint destruction and healing in radiographic imaging) scoring method.
Suto T; Yonemoto Y; Okamura K; Okura C; Kaneko T; Kobayashi T; Tachibana M; Tsushima Y; Takagishi K
Mod Rheumatol; 2017 Sep; 27(5):820-827. PubMed ID: 27919199
[TBL] [Abstract][Full Text] [Related]
37. Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial.
Rantalaiho V; Korpela M; Laasonen L; Kautiainen H; Järvenpää S; Hannonen P; Leirisalo-Repo M; Blåfield H; Puolakka K; Karjalainen A; Möttönen T;
Arthritis Res Ther; 2010; 12(3):R122. PubMed ID: 20576092
[TBL] [Abstract][Full Text] [Related]
38. [18F]fluorodeoxyglucose uptake as a predictor of large joint destruction in patients with rheumatoid arthritis.
Yonemoto Y; Okamura K; Takeuchi K; Kaneko T; Kobayashi T; Okura C; Tsushima Y; Takagishi K
Rheumatol Int; 2016 Jan; 36(1):109-15. PubMed ID: 26232929
[TBL] [Abstract][Full Text] [Related]
39. Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis.
Andersson ML; Svensson B; Petersson IF; Hafström I; Albertsson K; Forslind K; Heinegård D; Saxne T
BMC Musculoskelet Disord; 2013 Aug; 14():229. PubMed ID: 23915292
[TBL] [Abstract][Full Text] [Related]
40. Joint erosions and patients with early rheumatoid arthritis.
van der Heijde DM
Br J Rheumatol; 1995 Nov; 34 Suppl 2():74-8. PubMed ID: 8535653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
